The multispeciality approach to the management of localised kidney cancer

Review

关键词: RENAL-CELL CARCINOMA;    STEREOTACTIC ABLATIVE RADIOTHERAPY;    RADIOSURGERY ONCOLOGY CONSORTIUM;    OPEN RADICAL NEPHRECTOMY;    ACTIVE SURVEILLANCE;    ADJUVANT PEMBROLIZUMAB;    CARDIOVASCULAR EVENTS;    EUROPEAN ASSOCIATION;    SURGICAL-MANAGEMENT;    PATIENTS PTS;   

DOI  :  10.1016/S0140-6736(22)01059-5

来源: SCIE

【 摘 要 】

Historically, kidney cancer was approached in a siloed single-speciality way, with urological surgeons managing the localised stages of the disease and medical oncologists caring for patients if metastases developed. However, improvements in the management of localised kidney cancer have occurred rapidly over the past two decades with greater understanding of the disease biology, diagnostic options, and innovations in curative treatments. These developments are favourable for patients but provide a substantially more complex landscape for patients and clinicians to navigate, with associated challenging decisions about who to treat, how, and when. As such, the skill sets needed to manage the various aspects of the disease and guide patients appropriately outstrips the capabilities of one particular specialist, and the evolution of a multispeciality approach to the management of kidney cancer is now essential. In this Review, we summarise the current best multispeciality practice for the management of localised kidney cancer and the areas in need of further research and development.

【 授权许可】

Free